Roivant Sciences
Trade Roivant Sciences 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ROIV
Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses.
ROIV Key Statistics
Stock Snapshot
As of today, Roivant Sciences(ROIV) shares are valued at $28.49. The company's market cap stands at 20.38B, with a P/E ratio of -24.37.
Roivant Sciences(ROIV) stock opened on 2026-04-10 at $27.98. The price climbed to — and dipped to —.
The Roivant Sciences(ROIV)'s current trading volume is 0, compared to an average daily volume of 4.85M.
In the last year, Roivant Sciences(ROIV) shares hit a 52-week high of $30.33 and a 52-week low of $9.24.
In the last year, Roivant Sciences(ROIV) shares hit a 52-week high of $30.33 and a 52-week low of $9.24.
Analyst ratings
92%
of 12 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.